| Literature DB >> 34899859 |
Qian Zhang1,2, Yang Yu1,3, Zheng Luo1,2, Jianhai Xiang1,3, Fuhua Li1,3,4,5.
Abstract
Acute hepatopancreatic necrosis disease (AHPND) has caused a heavy loss to shrimp aquaculture since its outbreak. Vibrio parahaemolyticus (VPAHPND) is regarded as one of the main pathogens that caused AHPND in the Pacific white shrimp Litopenaeus vannamei. In order to learn more about the mechanism of resistance to AHPND, the resistant and susceptible shrimp families were obtained through genetic breeding, and comparative transcriptome approach was used to analyze the gene expression patterns between resistant and susceptible families. A total of 95 families were subjected to VPAHPND challenge test, and significant variations in the resistance of these families were observed. Three pairs of resistant and susceptible families were selected for transcriptome sequencing. A total of 489 differentially expressed genes (DEGs) that presented in at least two pairwise comparisons were screened, including 196 DEGs highly expressed in the susceptible families and 293 DEGs in the resistant families. Among these DEGs, 16 genes demonstrated significant difference in all three pairwise comparisons. Gene set enrichment analysis (GSEA) of all 27,331 expressed genes indicated that some energy metabolism processes were enriched in the resistant families, while signal transduction and immune system were enriched in the susceptible families. A total of 32 DEGs were further confirmed in the offspring of the detected families, among which 19 genes were successfully verified. The identified genes in this study will be useful for clarifying the genetic mechanism of shrimp resistance against Vibrio and will further provide molecular markers for evaluating the disease resistance of shrimp in the breeding program.Entities:
Keywords: Litopenaeus vannamei; Vibrio parahaemolyticus; disease resistance; gene expression; molecular marker
Year: 2021 PMID: 34899859 PMCID: PMC8662381 DOI: 10.3389/fgene.2021.772442
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1Survival rate of different families challenged by VPAHPND.
Primer sequences and annealing temperature used for RT-qPCR.
| Gene name | Forward primer (5′–3′) | Reverse primer (5′ to 3′) | Product size (bp) | Tm (°C) |
|---|---|---|---|---|
| ncbi_113822350 | ATTCCCTACAGTGACGACTA | GCCAAAAGATTCTCTCATGC | 132 | 51 |
| ncbi_113828004 | GTTCCAAACCCTACTTGTCT | CTATGTCCAAAACGGAATGC | 106 | 51 |
| XLOC_016514 | AGATGCTTCCCTGGATCAACC | TGGACTCTCCATTCCGATGTTC | 127 | 57 |
| XLOC_016534 | TCGCCATGAAGAACTGGTCA | GCAAATTGAAGGCGTCAGCA | 96 | 56 |
| ncbi_113824827 | TTGCGAGACAGACCAACCAG | CAGGTGCAATCTTCATCGCC | 133 | 55 |
| ncbi_113816316 | TTCCTCCCGCAAGACAAG | GAGGGAGGGTTGGGTTTT | 150 | 55 |
| ncbi_113816839 | CTTTCGGGAGGGAGCGTAT | ACGGGAATAGTCCATCCAAGT | 162 | 56 |
| ncbi_113810874 | ACCCGCTGTCCGCTCTACCA | TGTCCCAGCCGCAGCTCAAC | 118 | 64 |
| ncbi_113805286 | GGGCAACTTACGGCTTCT | TTCGTGCCAATGGGTTTC | 131 | 54 |
| ncbi_113826200 | ATTGCAGCACCGTCTCCT | TCCCTCAGGCAGACTTCG | 91 | 57 |
| XLOC_026751 | TCTTGTGCCTCGCTGTGG | GGTGATGTGCGTGATCTTCTT | 149 | 57 |
| ncbi_113826199 | CTCACCGCTGCGAGGATT | TCCCTCAGGCAGACTTCG | 106 | 58 |
| XLOC_023290 | TCTGCTGGTGATGATGGT | GTCATCGGGAGAACAACT | 142 | 52 |
| ncbi_113808761 | CCGCAATGCTGTAGAAGGAC | CGGCGGTCAGAGTGGAGAT | 149 | 58 |
| ncbi_113802520 | CTTCTTGCCGTGTTTGCC | ACGATGCCGTCTCCTGTCT | 164 | 57 |
| ncbi_113815780 | ACTCATAACCCACCGCCACT | TCGTCAGGGACCCAGCAA | 154 | 59 |
| ncbi_1,13820830 | AAGCCGAACTTGGAGGACC | CGGATGAACTTACCGAAACG | 110 | 56 |
| XLOC_016349 | CATCAAGCCCAAACCACC | TCTTCTCCAGCCAGCCACT | 104 | 58 |
| XLOC_016348 | ATTGGACGCAAGGAGTATGG | CCTGGGCTGGTTGATGAG | 146 | 55 |
| ncbi_1,13817858 | GAGGATGGGCTGAAATGTG | GTCCAGCAACTCTGAAGTATGA | 155 | 54 |
| ncbi_113825958 | GGAACAGCAGACGGGAGTG | CAACGAAGCATTGGTGGC | 93 | 57 |
| ncbi_113828431 | CCGTCACCAACACCCATAA | AGCAGCCACCCAAGGAAA | 150 | 56 |
| ncbi_113807930 | GCTCGTCACCACAACCAT | CGAAGATGGGAGGCAGGT | 145 | 56 |
| ncbi_113816695 | GAGCACCTCGCTTTCTGTTT | CATGACTTGGGTTCAGGTTTA | 107 | 54 |
| ncbi_113804592 | TCACGGAGTGCCGCTACGAT | TCCCTGTTGCGGATGTCCTG | 187 | 60 |
| ncbi_113813557 | CTGCCAGTGGAACACGCTAT | GCGGTGCTAGGAACGTAACTAA | 186 | 57 |
| ncbi_1,13817635 | ATGCTGACAAGGCGAATA | AAGAGTCAGACCCGCAAG | 159 | 52 |
| ncbi_113830625 | CGTGAATCGCAGTCCCTA | GTGGTCGCTTCCTCTTCC | 100 | 55 |
| ncbi_113807689 | GGCAGCCGCATCTTCATC | AGGGCGAAGCGGCGGTTGTT | 176 | 60 |
| ncbi_1,13819349 | GTTCCATACCGCCGTTACCA | CGAGCAATTTCGCTTACAACACTA | 119 | 55 |
| ncbi_113806536 | GCACTTCCAAAGCCAACGA | GATCTCCTCGGAGTTGTAGCG | 119 | 57 |
| ncbi_113802817 | CGTCGCTGGGCACAAGTA | AGCCGAAGTGTCCCGTTA | 167 | 57 |
| ncbi_1,13817262 | AATGAGGCGGAGGAGCAG | CCTTCCAGGTGGCAGACAG | 92 | 58 |
| ncbi_113821874 | TAAGAAGGTCCAGAGGCG | AACCCACAAGGCCATACA | 125 | 55 |
| ncbi_113810465 | CGCTGGTGGGTGTCGTGAT | CCGCTTGGCTGCTGAGAT | 117 | 55 |
| ncbi_113811111 | CCGAGGTCAACTACGAGG | ACGGGACTTGGTGGCTGGT | 106 | 55 |
| ncbi_113816327 | AAACCCAACCCTCCCTCT | TCCTCCGTCTCCAACACC | 136 | 54 |
| ncbi_113821801 | AAGGGCGTGGAAGGAATG | CTTCATCTCCTCCTTCTCCTTC | 187 | 56 |
| 18S | TATACGCTAGTGGAGCTGGAA | GGGGAGGTAGTGACGAAAAAT | 136 | 56 |
Summary of transcriptome sequencing and assembly of the transcriptome from Litopenaeus vannamei.
| Sample | Raw reads | Clean reads | Percentage remained (%) | Gene number |
|---|---|---|---|---|
| VR4013-1 | 43,410,372 | 42,125,030 | 97.04 | 20,485 |
| VR4013-2 | 57,672,500 | 55,606,214 | 96.42 | 20,677 |
| VR4013-3 | 51,479,718 | 49,787,374 | 96.71 | 21,014 |
| VR3837-1 | 38,338,506 | 36,947,962 | 96.37 | 19,828 |
| VR3837-2 | 37,704,754 | 36,467,784 | 96.72 | 19,592 |
| VR3837-3 | 47,019,886 | 45,527,220 | 96.83 | 20,211 |
| VR4027-1 | 56,229,492 | 54,118,212 | 96.25 | 21,034 |
| VR4027-2 | 39,363,752 | 37,908,938 | 96.30 | 20,832 |
| VR4027-3 | 44,978,148 | 43,327,096 | 96.33 | 20,310 |
| VS3868-1 | 42,426,736 | 41,120,350 | 96.92 | 20,912 |
| VS3868-2 | 42,975,552 | 41,754,004 | 97.16 | 20,621 |
| VS3868-3 | 41,490,144 | 40,033,320 | 96.49 | 20,573 |
| VS3880-1 | 51,220,018 | 49,705,886 | 97.04 | 20,157 |
| VS3880-2 | 45,819,944 | 44,689,240 | 97.53 | 20,289 |
| VS3880-3 | 42,021,826 | 40,653,124 | 96.74 | 20,005 |
| VS3879-1 | 49,914,612 | 48,181,284 | 96.53 | 20,111 |
| VS3879-2 | 43,730,322 | 42,164,296 | 96.42 | 19,971 |
| VS3879-3 | 47,364,768 | 45,863,282 | 96.83 | 20,366 |
FIGURE 2The amount of differentially expressed genes (DEGs) between resistant and susceptible families. UP represents highly expressed genes in susceptible families. DOWN represents highly expressed genes in resistant families.
FIGURE 3Enrichment analysis of differentially expressed genes (DEGs). (A) Gene Ontology (GO) terms distribution for the DEGs. Light gray represents VR4013-vs.-VR3868. Gray represents VR3837-vs.-VR3879. Dark gray represents VR4027-vs.-VR3880. The x-axis indicates the name of GO subcategories. The y-axis represents the number of genes. (B) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enriched about DEGs in VR4013-vs.-VR3868, VR3837-vs.-VR3879, and VR4027-vs.-VR3880.
FIGURE 4Venn diagrams for three pairwise comparisons of resistant and susceptible families. (A) Differentially expressed genes (DEGs) with high expression in susceptible families. (B) DEGs with high expression in resistant families.
Gene name, gene annotation, and the verification in hepatopancreas (Hep) and stomach (St) of 16 DEGs that were shared in three pairwise comparisons.
| Gene name | Gene annotation | Verification ( | |
|---|---|---|---|
| Hep | St | ||
| ncbi_113805286 | NA | √(0.001) | |
| ncbi_113810874 | Trophoblast glycoprotein | √(0.024) | |
| ncbi_113826200 | NA | √(0.025) | |
| XLOC_016514 | NA | √(0.004) | |
| XLOC_016534 | NA | ||
| ncbi_113822350 | SE-cephalotoxin-like | √(0.004) | √(0.01) |
| ncbi_113824827 | Prolow-density lipoprotein receptor-related protein 1-like | √(0.018) | √(0.013) |
| ncbi_113828004 | Peroxidasin-like protein | √(0.02) | |
| ncbi_113819349 | Phosphoenolpyruvate carboxykinase, cytosolic | ||
| ncbi_113807689 | Cytochrome P450 | ||
| XLOC_026751 | NA | √(0.006) | √(0.014) |
| ncbi_113826199 | Single insulin-like growth factor-binding domain protein-2 | √(0.003) | √(0.009) |
| XLOC_023290 | NA | √(0.012) | |
| ncbi_113825958 | Serpin B6-like isoform X2 | ||
| ncbi_113816327 | NA | ||
| ncbi_113816316 | NA | √(0.023) | |
Note. The threshold for significance is p-value < 0.05.
DEGs, differentially expressed genes.
NA indicates that the function of gene is unknown.
FIGURE 5Gene Ontology (GO) terms of 489 differentially expressed genes (DEGs) for the transcriptomes of Litopenaeus vannamei. The x-axis indicates the name of GO subcategories. The y-axis indicates the number of genes. Red indicates biological process. Green indicates cellular component. Blue displays molecular function.
Myosin- and energy metabolism-related DEGs with high expression in VPAHPND-resistant Litopenaeus vannamei families.
| Gene ID | Description | Species |
|---|---|---|
| ncbi_113815780 | Myosin-16-like |
|
| ncbi_113820830 | Myosin-16 isoform X2 |
|
| XLOC_031566 | Myosin heavy chain, muscle-like isoform X7 |
|
| ncbi_113816531 | Myosin-7 |
|
| XLOC_016349 | Myosin heavy chain type 2 |
|
| XLOC_016348 | Myosin heavy chain type 2 |
|
| XLOC_016355 | Myosin heavy chain type b |
|
| XLOC_015656 | Myosin heavy chain type b |
|
| ncbi_113802000 | Myosin heavy chain, partial |
|
| XLOC_009141 | Actin 2 |
|
| ncbi_113815891 | Tryptase-like |
|
| ncbi_113822347 | Tryptase-2-like |
|
| ncbi_113813760 | Trypsin-like |
|
| ncbi_113809217 | Trypsin-2-like |
|
| ncbi_113814573 | Chymotrypsinogen A |
|
| ncbi_113806996 | Serine protease 33-like |
|
| ncbi_113800311 | Serine protease 27-like |
|
| XLOC_005102 | Aminopeptidase N-like |
|
| ncbi_113815289 | Aminopeptidase N |
|
| ncbi_113815282 | Aminopeptidase N |
|
| ncbi_113815313 | Aminopeptidase N |
|
| ncbi_113815275 | Aminopeptidase Ey-like |
|
| ncbi_113811393 | Aminopeptidase Ey-like |
|
| ncbi_113804819 | Aminopeptidase Ey-like |
|
| ncbi_113804804 | Aminopeptidase N, partial |
|
| XLOC_009027 | Cathepsin l, partial |
|
| ncbi_113807506 | Pancreatic lipase-related protein 2-like |
|
| ncbi_113821709 | Phospholipase A2 |
|
| ncbi_113808761 | Alkaline phosphatase, tissue-nonspecific isozyme-like |
|
| ncbi_1,13820123 | Glyceraldehyde 3-phosphate dehydrogenase |
|
| ncbi_113802551 | Triosephosphate isomerase A |
|
Note. DEGs, differentially expressed genes.
Immunity-related DEGs with high expression in VPAHPND-susceptible Litopenaeus vannamei families.
| Gene ID | Description | Species |
|---|---|---|
| ncbi_113817858 | C-type lectin domain family 4 member E-like isoform X3 |
|
| ncbi_113825958 | Serpin B6-like isoform X2 |
|
| ncbi_113828431 | Serine protease 42-like |
|
| ncbi_113808061 |
|
|
| ncbi_113808062 |
|
|
| ncbi_113816695 | DBH-like monooxygenase protein 1 |
|
| ncbi_113804592 | DBH-like monooxygenase protein 1 |
|
| ncbi_113813557 | Cytochrome b5-like |
|
| ncbi_113807689 | Cytochrome P450 |
|
| ncbi_113829525 |
|
|
| ncbi_113826122 |
|
|
| ncbi_113815019 |
|
|
| ncbi_113822594 |
|
|
| ncbi_113804603 |
|
|
| ncbi_113807566 |
|
|
Note. DEGs, differentially expressed genes.
GSEA of GO gene sets.
| EP | Gene set | Size | NES | Nom | FDR |
|---|---|---|---|---|---|
| R | Mitochondrial_protein_complex | 78 | 2.70 | 0 | 0 |
| R | Inner_mitochondrial_membrane_protein_complex | 36 | 2.64 | 0 | 0 |
| R | Cellular_respiration | 64 | 2.61 | 0 | 0 |
| R | Oxidative_phosphorylation | 44 | 2.58 | 0 | 0 |
| R | Mitochondrial_respiratory_chain_complex_assembly | 33 | 2.57 | 0 | 0 |
| R | Respiratory_electron_transport_chain | 40 | 2.54 | 0 | 0 |
| R | Respiratory_chain_complex | 27 | 2.53 | 0 | 0 |
| R | ATP_synthesis_coupled_electron_transport | 35 | 2.52 | 0 | 0 |
| R | NADH_dehydrogenase_complex_assembly | 26 | 2.49 | 0 | 0 |
| R | Respirasome | 35 | 2.44 | 0 | 0 |
| S | G_Protein_coupled_receptor_activity | 52 | −2.16 | 0 | 0.119 |
| S | G_Protein_coupled_receptor_signaling_pathway | 115 | −2.11 | 0 | 0.130 |
| S | Tight_junction | 18 | −2.10 | 0 | 0.101 |
| S | Positive_regulation_of_blood_circulation | 8 | −2.10 | 0 | 0.078 |
| S | Solute_sodium_symporter_activity | 32 | −2.10 | 0 | 0.066 |
| S | Neurotransmitter_binding | 17 | −2.10 | 0 | 0.055 |
| S | Neuromuscular_process_controlling_balance | 10 | −2.09 | 0 | 0.048 |
| S | Apical_junction_complex | 18 | −2.05 | 0.003 | 0.072 |
| S | Serine_type_endopeptidase_inhibitor_activity | 17 | −2.05 | 0.003 | 0.069 |
| S | Pattern_recognition_receptor_signaling_pathway | 27 | −2.02 | 0 | 0.085 |
Note. EP, enrichment in phenotype, gene sets enriched in nine resistant (R) samples or nine susceptible (S) samples; Size, number of genes in the gene set; NES, normalized enrichment score; NOM p-value, nominal p-value, the statistical significance of the enrichment score; FDR, false discovery rate; GSEA, Gene set enrichment analysis; GO, Gene Ontology.
FIGURE 6Gene set enrichment analysis (GSEA) of Kyoto Encyclopedia of Genes and Genomes (KEGG) subset of canonical pathways. (A) The most significantly enriched pathway in resistant families. (B) The most significantly enriched pathway in susceptible families. R, resistant samples; S, susceptible samples. Nominal p-value, false discovery rate (FDR), enrichment score (ES), and normalized ES were determined by the GSEA software and were indicated within each enrichment plot.
FIGURE 7The relative expression of 32 differentially expressed genes (DEGs) in hepatopancreas (A) and stomach (B) from resistant family 4253 and susceptible family 4019. These data are expressed as the mean ± SD relative to the reference gene (18S rRNA). A statistically significant difference is indicated with * (p < 0.05) and ** (p < 0.01). Successfully verified genes are marked in red. Unsuccessfully verified genes are marked in black or without any mark.